Clinical trials
Terminated Immune System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| Seagen Inc. | 2 |
| miRagen Therapeutics, Inc. | 2 |
| Adienne SA | 1 |
| Alladapt Immunotherapeutics, Inc. | 1 |
| Amgen | 1 |
| Ariad Pharmaceuticals | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 31 |
| Immunoproliferative Disorders | 9 |
| Lymphatic Diseases | 9 |
| Lymphoproliferative Disorders | 9 |
| Lymphoma | 8 |
| Lymphoma, Non-Hodgkin | 8 |
| Neoplasms | 8 |
| Autoimmune Diseases | 5 |
| Connective Tissue Diseases | 5 |
| Hematologic Diseases | 5 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.